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OBJECTIVES: The Morisky Medication Adherence Scale (MMAS) has been widely 
used to measure medication adherence; whereas the Adherence to Refills and 
Medications Scale (ARMS) was developed to measure medication adherence 
among elderly population. The objective of the study was to assess medication 
adherence among young adults by using ARMS as well as MMAS and to evaluate 
determine which scales helps better in determining predictors of medication non 
adherence among young adults. METHODS: A cross-sectional survey was 
conducted in a sample of students attending a large university. A validated 
survey instrument was used to obtain information on socio-demographic 
variables, medication behavior, and factors responsible for non-adherence. 
Medication adherence was measured using MMAS (six questions) on a 
dichotomous (yes/no) scale with 'yes' being medically non-adherent and ARMS 
scale with 12 questions on a 4-point Likert scale. Reliability was assessed using 
Cronbach’s alpha. Multiple regression analysis was conducted to assess 
predictors of non-adherence for both the scales. RESULTS: A total of 300 
completed surveys were received (response rate 86%). Mean (SD) age of the 
sample was 23.4 (4.3) years. Participants indicated they were adherent with their 
medication therapy where mean (SD) ARMS score was 1.7 (0.4) (≤2 considered 
adherent) and MMAS scores was 2.6 (1.9) (≤3 considered adherent). Spearman 
correlation coefficient was 0.71 (p<0.0001). Predictors of medication non 
adherence using the ARMS were: forgetfulness (β:0.25, p<0.0001), time constraint 
(β:0.18, p=0.0004), social stigma (β:0.14, p<0.0001), gender (β:-0.09, p=0.01) and 
difficulty in remembering all medications (β:0.09, p=0.0003); whereas that using 
the MMAS were: forgetfulness (β:1.07, p=0.003) and difficulty in remembering all 
medications (β:1.41, p<0.0001). CONCLUSIONS: Medication adherence 
information obtained using ARMS were able to identify more predictors 
compared to MMAS in the cohort of young adults. Future application of the 
scales to different populations could be beneficial.  
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OBJECTIVES: Research on medication adherence has revealed that majority of 
the adult population encounter problems in compliance with prescribed 
medication. The objectives of this study were to evaluate the extent of 
medication adherence among a diverse cohort of university students and 
determine factors that hamper their adherence to prescribed medications. 
METHODS: A cross-sectional survey was conducted among students attending a 
larger minority designated Tier I University in the state of Texas. The validated 
instrument administered consisted of 41 questions on four domains: socio-
demographic, medication behavior, extent of medication adherence, and reasons 
for non-adherence. Reliability was assessed using Cronbach’s alpha. For extent 
of medication adherence/non-adherence, ‘One Sample T-test’ was conducted 
and for the factors leading to medication non-adherence, multiple regression 
analysis was used. RESULTS: A total of 300 completed survey were obtained 
(response rate 86%). The mean age of sample was 23.39 years (SD: 4.32). The 
sample distribution by ethnicity was Hispanics (32%), Asians (31%) and Whites 
non-hispanic (22%), African American (12%) and other (3%). The overall mean 
medication adherence score was 1.77 (SD: 0.44) (scale 1= never missing a dose to 
4= always missing a dose). Most (73.3%) were identified as "medically adherent" 
(mean medication adherence score ≤ 2). Controlling for all other factors (age, 
race, educational level, current major, insurance status, relationship status, 
current medication, number of medications in last month, chronic conditions 
and social stigma), following were found to be significant predictors that hamper 
medication adherence: forgetfulness (β: 0.2511, p<0.0001), time constraint (β: 
0.1801, p=0.0004), social stigma (β: 0.1416, p<0.0001), gender (β: -0.0907, p=0.0119) 
and difficulty in remembering all medications (β: 0.0917, p=0.0003). 
CONCLUSIONS: Our cohort of young diverse university students was found to be 
medically adherent. However, forgetfulness, time constraint, social stigma, 
gender and difficulty in remembering all medications were found significant in 
hampering their medication adherence.  
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OBJECTIVES: The PPIUS, previously validated, is a single-item patient-reported 
rating scale that captures degree of urgency associated with micturition and/or 
incontinence. We sought to establish the MID of the PPIUS in patients with lower 
urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia 
(BPH). METHODS: Patients with LUTS associated with BPH enrolled in a Phase III, 
randomized, double-blind, 12-week study of fixed dose combinations of 
solifenacin succinate with tamsulosin hydrochloride Oral Controlled Absorption 
System (OCAS), OCAS monotherapy, and placebo completed the PPIUS prior to 
visits two (baseline), three, four, and five (end of study [EOS]). Three separate 
scores were derived from the PPIUS including the Total Urgency Score (TUS), 
mean number of urgency episodes (PPIUS grade three and four) (MNUE), and 
urgency-incontinence episodes (MNUIE) per 24 hours (for those with >1 
incontinence episode). Two Patient Global Impression (PGI) ratings and a Clinical 
Global Impression (CGI) rating were completed at baseline and EOS. Anchor- and 
distribution-based MID estimates for the PPIUS were calculated. RESULTS: 1,184 
males were enrolled (99% Caucasian; mean age: 65; mean BMI: 28 kg/m2). 
Correlation analyses supported using CGI and PGI ratings at EOS as anchors for 
the TUS and one PGI rating for the MNUE. Correlations were too low to estimate 
the MID for the MNUIE. A 1-unit change in PGI and CGI ratings predicted a 
change of 3.95-5.79 for TUS and 1.86 for MNUE. Distribution-based estimates 
resulted in a minimal detectable change (MDC) of 4.57 for TUS and 1.50 for 
MNUE. After integrating anchor- and distribution-based estimates, the MID 
estimates for TUS were 5.5-6.0 and 1.8-2.0 for MNUE. CONCLUSIONS: MID 
estimates provide guidance for defining clinically meaningful changes, defining 
a clinical responder, and examining cumulative distribution functions. Future 
research should confirm these estimates using patients whose condition 
worsened, and using more relevant anchors for the MNUIE.  
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OBJECTIVES: Translation of patient reported outcomes (PRO) measures is an 
essential component of the research methodology required when preparing for 
multinational clinical trials. One such measure is the Functional Assessment of 
Chronic Illness Therapy-Dyspnea questionnaire (FACIT-Dyspnea), which 
evaluates the quality of life (QOL) of patients suffering from dyspnea. METHODS: 
This study was designed to linguistically validate the FACIT-Dyspnea scale for 
use in Australia, Austria, Belgium, Brazil, Canada, China, Czech Republic, 
Denmark, Hungary, Hong Kong, Ireland, Italy, Mexico, New Zealand, South 
Korea, Poland, Taiwan, and the UK. The combined sample consisted of 130 
patients (62 males/68 females) who were experiencing dyspnea. Patient mean 
age was 58 years, and 118 patients were receiving treatment at the time of 
administration. The sample consisted of patients who speak Chinese, Czech, 
Danish, Dutch, English, French, German, Hungarian, Italian, Korean, Polish, 
Portuguese and Spanish. The FACIT-Dyspnea was translated based on the 
established FACIT methodology. Patients completed the respective translated 
questionnaire and then participated in cognitive interviews to determine if there 
were any problems with the translations or item content. Qualitative analyses 
were performed in order to confirm the validity of the translations. RESULTS: 
During the translation process, some items proved difficult to translate for other 
cultures (e.g. “flights of stairs”, “sweeping and mopping”). Once all issues were 
resolved the FACIT-Dyspnea translations were well understood and relevant to 
patients from a wide range of countries and cultures. Very few items required 
modifications to translations as a result of pilot-testing. CONCLUSIONS: The 
FACIT-Dyspnea demonstrated linguistic validity across all 14 languages. The 
translations are considered acceptable for PRO assessment in international 
research and clinical trials.  
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OBJECTIVES: In the last years, the assessment of patient satisfaction has become 
a field of interest for public authorities, researchers, and clinicians due to its 
implications specially, in the management of chronic diseases. To this purpose 
the SAT-Q is a questionnaire for measuring patient satisfaction which has been 
developed and validated from a Classical Test Theory (CTT) approach, resulting 
in a 18 item version. The objective of this research focuses on the application of 
the Rasch model in selecting and testing the most appropriate items for the 
assessment of the satisfaction related to pharmacological treatments. 
METHODS: The sample consisted of a total of 202 patients diagnosed with 
chronic illness who were following a pharmacological regimen for at least one 
year. Data were analyzed using the Rasch Partial Credit Model. Parameter 
estimation, model-fit data and separation statistics were computed and 
compared to CTT validation, in order to select those items with better 
psychometrical properties. RESULTS: Misfiting items were deleted, resulting in a 
10 items version. This short form of the SAT-Q showed good model fit and 
represented an accurate measure of the construct. Infit MNSQ ranged from 0.75 
to 1.51 (SD=0.25) and outfit MNSQ ranged from 0.68 to 2.24 (SD=0.45). Person 
separation index and item reliability were 1.90 and 0.97 respectively. Principal 
Component Analysis (PCA) also distinguished a main component that accounted 
for 54.5% of total variance. Score correlation with CTT validation version was 
0.83. On the other hand, item-person map showed that the test was off-target 
and didn’t cover the wide range of the ability scale. CONCLUSIONS: SAT-Q short 
form version has adequate psychometric properties in terms of goodness-of-fit-
test, reliability and validity. Future research is recommended to improve 
discrimination between different degrees of satisfaction and reducing the ceiling 
effect associated with the satisfaction measures.  
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OBJECTIVES: There appears to be limited agreement about the appropriate 
length of interval required between two administrations of a PRO in a test-retest 
or equivalence study. The objective of this literature review was to determine 
